核仁素与肿瘤生物学行为的关系

摘要/Abstract

摘要： 核仁素的异常表达存在于多种疾病进展中，特别会影响炎症反应、病毒感染、肿瘤等疾病的发生和进展。核仁素在多种肿瘤中表达量升高，分布位置发生变化，影响肿瘤细胞增殖、凋亡、肿瘤转移等多个过程。

Abstract: Nucleolin is implicated in many pathological processes, particularly in inflammatory diseases, viral infection and neoplasms. Nucleolin levels are increased in several neoplasms and its localization changed, which play important roles in cell proliferation, apoptosis and metastasis of neoplasms.

Key words: Neoplasms, Cell proliferation, Apoptosomes, Neoplasm metastasis

王晓, 高勇, 李砚东. 核仁素与肿瘤生物学行为的关系[J]. 国际肿瘤学杂志, 2016, 43(2): 119-.

WANG Xiao, GAO Yong, LI Yan-Dong. The correlation between nucleolin and biological behavior of tumor[J]. Journal of International Oncology, 2016, 43(2): 119-.

参考文献

［1］ Durut N, SáezVásquez J. Nucleolin: dual roles in rDNA chromatin transcription［J］. Gene, 2015, 556(1): 712. DOI:10.1016/j.gene.2014.09.023. ［2］ Abdelmohsen K, Gorospe M. RNAbinding protein nucleolin in disease［J］. RNA Biol, 2012, 9(6): 799808. DOI:10.4161/rna.19718. ［3］ Berger CM, Gaume X, Bouvet P. The roles of nucleolin subcellular localization in cancer［J］. Biochimie, 2015, 113: 7885. DOI:10.1016/j.biochi.2015.03.023. ［4］ Guo X, Xiong L, Yu L, et al. Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy［J］. Diagn Pathol, 2014, 9: 175. DOI:10.1186/s130000140175y. ［5］ Qiu W, Zhou F, Zhang Q, et al. Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer［J］. APMIS, 2013, 121(10): 919925. DOI:10.1111/apm.12131. ［6］ Koutsioumpa M, Polytarchou C, Courty J, et al. Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration［J］. J Biol Chem, 2013, 288(1): 343354. DOI:10.1074/jbc.M112.387076. ［7］ Fujiki H, Watanabe T, Suganuma M. Cellsurface nucleolin acts as a central mediator for carcinogenic, anticarcinogenic, and diseaserelated ligands［J］. J Cancer Res Clin Oncol, 2014, 140(5): 689699. DOI:10.1007/s0043201415875. ［8］ Qi J, Li H, Liu N, et al. The implications and mechanisms of the extranuclear nucleolin in the esophageal squamous cell carcinomas［J］. Med Oncol, 2015, 32(3): 45. DOI:10.1007/s1203201504843. ［9］ Xiao S, Caglar E, Maldonado P, et al. Induced expression of nucleolin phosphorylationdeficient mutant confers dominantnegative effect on cell proliferation［J］. PLoS One, 2014, 9(10): e109858. DOI:10.1371/journal.pone.0109858. ［10］ Wu DM, Zhang P, Liu RY, et al. Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K/Akt pathway in colorectal carcinoma［J］. FEBS Lett, 2014, 588(10): 19211929. DOI:10.1016/j.febslet.2014.03.047. ［11］ Wang W, Luo J, Xiang F, et al. Nucleolin downregulation is involved in ADPinduced cell cycle arrest in S phase and cell apoptosis in vascular endothelial cells［J］. PLoS One, 2014, 9(10): e110101. DOI:10.1371/journal.pone.0110101. ［12］ Srivastava A, Srivastava S, Bansal C, et al. Diagnostic importance of AgNOR pleomorphism in cervical carcinogenesis［J］. Ecancermedicalscience, 2013, 7: 287. DOI:10.3332/ecancer.2013.287. ［13］ Malik MT, O′toole MG, Casson LK, et al. AS1411conjugated Gold nanospheres and their potential for breast cancer therapy［J］. Oncotarget, 2015, 6(26): 2227022281. ［14］ Liao ZX, Chuang EY, Lin CC, et al. An AS1411 aptamerconjugated liposomal system containing a bubblegenerating agent for tumorspecific chemotherapy that overcomes multidrug resistance［J］. J Control Release, 2015, 208: 4251. DOI:10.1016/j.jconrel.2015.01.032. ［15］ Wang WH, Childress MO, Geahlen RL. Syk interacts with and phosphorylates nucleolin to stabilize Bclx(L) mRNA and promote cell survival［J］. Mol Cell Biol, 2014, 34(20): 37883799. DOI:10.1128/MCB.0093714. ［16］ Wise JF, Berkova Z, Mathur R, et al. Nucleolin inhibits Fas ligand binding and suppresses Fasmediated apoptosis in vivo via a surface nucleolinFas complex［J］. Blood, 2013, 121(23): 47294739. DOI:10.1182/blood201212471094. ［17］ Cheng DD, Zhao HG, Yang YS, et al. GSK3β negatively regulates HIF1α mRNA stability via nucleolin in the MG63 osteosarcoma cell line［J］. Biochem Biophys Res Commun, 2014, 443(2): 598603. DOI:10.1016/j.bbrc.2013.12.020. ［18］ Sletten T, Kostas M, Bober J, et al. Nucleolin regulates phosphorylation and nuclear export of fibroblast growth factor 1 (FGF1)［J］. PLoS One, 2014, 9(3): e90687. DOI:10.1371/journal.pone.0090687. ［19］ Hsu TI, Lin SC, Lu PS, et al. MMP7mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy［J］. Oncogene, 2015, 34(7): 826837. DOI:10.1038/onc.2014.22. ［20］ Subramanian N, Kanwar JR, Akilandeswari B, et al. Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery［J］. Chem Commun (Camb), 2015, 51(32): 69406943. DOI:10.1039/c5cc00939a. ［21］ Lee JW, Kim HJ, Heo K. Therapeutic aptamers: developmental potential as anticancer drugs［J］. BMB Rep, 2015, 48(4): 234237. ［22］ Qiu W, Wang G, Sun X, et al. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma［J］. Med Oncol, 2015, 32(3): 75. DOI:10.1007/s1203201505301. ［23］ Goldstein M, Derheimer FA, TaitMulder J, et al. Nucleolin mediates nucleosome disruption critical for DNA doublestrand break repair［J］. Proc Natl Acad Sci USA, 2013, 110(42): 1687416879. DOI:10.1073/pnas.1306160110. ［24］ Koutsioumpa M, Papadimitriou E. Cell surface nucleolin as a target for anticancer therapies［J］. Recent Pat Anticancer Drug Discov, 2014, 9(2): 137152.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.